ArticleArXiv2023
deepPERFECT: Novel Deep Learning CT Synthesis Method for Expeditious Pancreatic Cancer Radiotherapy.
Article in ArXiv, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer with more than 60,000 new cases each year has less than 10 percent 5-year overall survival. Radiation therapy (RT) is an effective treatment for Locally advanced pancreatic cancer (LAPC). The current clinical RT workflow is lengthy and involves separate image acquisition for diagnostic CT (dCT) and planning CT (pCT). Studies have shown a reduction in mortality rate from expeditious radiotherapy treatment. dCT and pCT are acquired separately because of the differences in the image acquisition setup and patient body. We are presenting deepPERFECT: deep learning-based model to adapt the shape of the patient body on dCT to the treatment delivery setup. Our method expedites the treatment course by allowing the design of the initial RT planning before the pCT acquisition. Thus, the physicians can evaluate the potential RT prognosis ahead of time, verify the plan on the treatment day-one CT and apply any online adaptation if needed. We used the data from 25 pancreatic cancer patients. The model was trained on 15 cases and tested on the remaining ten cases. We evaluated the performance of four different deep-learning architectures for this task. The synthesized CT (sCT) and regions of interest (ROIs) were compared with ground truth (pCT) using Dice similarity coefficient (DSC) and Hausdorff distance (HD). We found that the three-dimensional Generative Adversarial Network (GAN) model trained on large patches has the best performance. The average DSC and HD for body contours were 0.93, and 4.6 mm. We found no statistically significant difference between the synthesized CT plans and the ground truth. We showed that employing deepPERFECT shortens the current lengthy clinical workflow by at least one week and improves the effectiveness of treatment and the quality of life of pancreatic cancer patients.
Identifiers
36748001PMC9900959What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.